Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2015

01-08-2015 | Original Article

Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults

Authors: Ralph Hurley O’Dwyer, Andrés Acosta, Michael Camilleri, Duane Burton, Irene Busciglio, Adil E. Bharucha

Published in: Digestive Diseases and Sciences | Issue 8/2015

Login to get access

Abstract

Background

Chronic megacolon is a rare disease of the colonic motor function characterized by a permanent increase in colonic diameter.

Methods

We reviewed electronic medical records of all patients diagnosed with chronic megacolon from 1999 to 2014 at Mayo Clinic. Our aim was to summarize clinical and motility features, including colonic compliance and tone measured by colonic barostat-controlled 10-cm-long infinitely compliant balloon. Colonic compliance curves were compared to healthy control (40) and disease (47) control groups.

Results

Among 24 identified patients, the mean maximal colonic diameter on abdominal radiograph was 12.7 ± 0.8 cm. The cause of megacolon was idiopathic in 16 of 24 and secondary in 8 of 24. A relatively high prevalence (10/24) of comorbid pelvic floor dyssynergia was identified. At the time of this report, 16 patients had undergone colectomy. In general, megacolon presented high fasting colonic volume at relatively low pressures (16–20 mmHg), suggesting high colonic compliance; similarly, volumes at operating pressures that ensured apposition of the balloon to the colonic wall suggested low colonic tone. Median balloon volume at 44 mmHg distension was 584 mL (IQR 556.5–600) in patients with megacolon compared to 251 mL (212–281) in healthy, 240 mL (207–286) in functional constipation, and 241 mL (210.8–277.5) in diarrhea-predominant irritable bowel syndrome controls. Colon’s tonic response to feeding was generally intact, and there was frequently maintained phasic contractile response to feeding.

Conclusions

Chronic megacolon is a severe colonic dysmotility, manifesting radiologically with increased colonic diameter; it can be proven by measuring colonic compliance and typically requires colectomy because of failed medical therapy.
Literature
1.
go back to reference Torretta A, Mascagni D, Zeri K, et al. The megacolon in myotonic dystrophy: case report and review of the literature. Ann Ital Chir. 2000;71:729–733.PubMed Torretta A, Mascagni D, Zeri K, et al. The megacolon in myotonic dystrophy: case report and review of the literature. Ann Ital Chir. 2000;71:729–733.PubMed
2.
go back to reference Sáinz R, Lanas A, Gomollón F, Moros M. Megacolon in Duchenne’s disease. Gastroenterology. 1982;83:1155–1156.PubMed Sáinz R, Lanas A, Gomollón F, Moros M. Megacolon in Duchenne’s disease. Gastroenterology. 1982;83:1155–1156.PubMed
3.
go back to reference Moore S, Schneider J, Kaschala R. Non-familial visceral myopathy: clinical and pathologic features of degenerative leiomyopathy. Pediatr Surg Int. 2002;18:6–12.PubMedCrossRef Moore S, Schneider J, Kaschala R. Non-familial visceral myopathy: clinical and pathologic features of degenerative leiomyopathy. Pediatr Surg Int. 2002;18:6–12.PubMedCrossRef
4.
go back to reference Martucciello G. Hirschsprung’s disease, one of the most difficult diagnoses in pediatric surgery: a review of the problems from clinical practice to the bench. Eur J Pediatr Surg. 2008;18:140–149.PubMedCrossRef Martucciello G. Hirschsprung’s disease, one of the most difficult diagnoses in pediatric surgery: a review of the problems from clinical practice to the bench. Eur J Pediatr Surg. 2008;18:140–149.PubMedCrossRef
5.
go back to reference Ibanez C, Fernandez-Gonzalez I. Emergency anesthesia in a woman with mitochondrial neurogastrointestinal encephalopathy. Rev Esp Anestesiol Reanim. 2011;58:585–587.PubMedCrossRef Ibanez C, Fernandez-Gonzalez I. Emergency anesthesia in a woman with mitochondrial neurogastrointestinal encephalopathy. Rev Esp Anestesiol Reanim. 2011;58:585–587.PubMedCrossRef
6.
go back to reference Muehlenberg K, Fiedler A, Schaumann I, Muller-Felber W, Wiedmann KH. Intestinal pseudoobstructions and gastric necrosis in mitochondrial myopathy. Dtsch Med Wochenschr. 2002;127:611–615.PubMedCrossRef Muehlenberg K, Fiedler A, Schaumann I, Muller-Felber W, Wiedmann KH. Intestinal pseudoobstructions and gastric necrosis in mitochondrial myopathy. Dtsch Med Wochenschr. 2002;127:611–615.PubMedCrossRef
8.
go back to reference Lee J, Park H, Kamm M, Talbot I. Decreased density of interstitial cells of cajal and neuronal cells in patients with slow-transit constipation and acquired megacolon. J Gastroenterol Hepatol. 2005;20:1292–1298.PubMedCrossRef Lee J, Park H, Kamm M, Talbot I. Decreased density of interstitial cells of cajal and neuronal cells in patients with slow-transit constipation and acquired megacolon. J Gastroenterol Hepatol. 2005;20:1292–1298.PubMedCrossRef
9.
go back to reference Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459–1467.PubMedCrossRef Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459–1467.PubMedCrossRef
10.
go back to reference Iantorno G, Bassotti G, Kogan Z, et al. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol. 2007;31:460–468.PubMedCrossRef Iantorno G, Bassotti G, Kogan Z, et al. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol. 2007;31:460–468.PubMedCrossRef
11.
go back to reference Kupsky W, Grimes M, Sweeting J, Bertsch R, Cote L. Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology. 1987;37:1253–1255.PubMedCrossRef Kupsky W, Grimes M, Sweeting J, Bertsch R, Cote L. Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology. 1987;37:1253–1255.PubMedCrossRef
12.
go back to reference Di Lorenzo C, Flores AF, Reddy SN, Snape WJ Jr, Bazzocchi G, Hyman PE. Colonic manometry in children with chronic intestinal pseudo-obstruction. Gut. 1993;34:803–807.PubMedCentralPubMedCrossRef Di Lorenzo C, Flores AF, Reddy SN, Snape WJ Jr, Bazzocchi G, Hyman PE. Colonic manometry in children with chronic intestinal pseudo-obstruction. Gut. 1993;34:803–807.PubMedCentralPubMedCrossRef
13.
go back to reference Preston DM, Lennard-Jones JE, Thomas BM. Towards a radiologic definition of idiopathic megacolon. Gastrointest Radiol. 1985;10:167–169.PubMedCrossRef Preston DM, Lennard-Jones JE, Thomas BM. Towards a radiologic definition of idiopathic megacolon. Gastrointest Radiol. 1985;10:167–169.PubMedCrossRef
14.
go back to reference Camilleri M. Dysmotility of the small intestine and colon. In: Yamada T, ed. Textbook of gastroenterology. Wiley-Blackwell: Hoboken, NJ; 2009:1513–1520. Camilleri M. Dysmotility of the small intestine and colon. In: Yamada T, ed. Textbook of gastroenterology. Wiley-Blackwell: Hoboken, NJ; 2009:1513–1520.
15.
go back to reference Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007;293:G137–G145.PubMedCrossRef Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007;293:G137–G145.PubMedCrossRef
16.
go back to reference Camilleri M, Busciglio I, Acosta A, et al. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014;109:1621–1630.PubMedCrossRef Camilleri M, Busciglio I, Acosta A, et al. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014;109:1621–1630.PubMedCrossRef
17.
go back to reference Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology. 2010;138:89–97.PubMedCentralPubMedCrossRef Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology. 2010;138:89–97.PubMedCentralPubMedCrossRef
18.
go back to reference von der Ohe M, Hanson R, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994;6:213–222.CrossRef von der Ohe M, Hanson R, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994;6:213–222.CrossRef
19.
go back to reference Arkwright JW, Dickson A, Maunder SA, et al. The effect of luminal content and rate of occlusion on the interpretation of colonic manometry. Neurogastroenterol Motil. 2013;25:e52–e59.PubMedCentralPubMedCrossRef Arkwright JW, Dickson A, Maunder SA, et al. The effect of luminal content and rate of occlusion on the interpretation of colonic manometry. Neurogastroenterol Motil. 2013;25:e52–e59.PubMedCentralPubMedCrossRef
20.
go back to reference van den Berg MM, Di Lorenzo C, Mousa HM, Benninga MA, Boeckxstaens GE, Luquette M. Morphological changes of the enteric nervous system, interstitial cells of cajal, and smooth muscle in children with colonic motility disorders. J Pediatr Gastroenterol Nutr. 2009;48:22–29.PubMedCrossRef van den Berg MM, Di Lorenzo C, Mousa HM, Benninga MA, Boeckxstaens GE, Luquette M. Morphological changes of the enteric nervous system, interstitial cells of cajal, and smooth muscle in children with colonic motility disorders. J Pediatr Gastroenterol Nutr. 2009;48:22–29.PubMedCrossRef
21.
go back to reference Tomita R, Sakurai K, Fujisaki S, Shibata M. Role of the enteric nervous system in the colon of patients with idiopathic megacolon. Hepatogastroenterology. 2012;59:2127–2131.PubMedCrossRef Tomita R, Sakurai K, Fujisaki S, Shibata M. Role of the enteric nervous system in the colon of patients with idiopathic megacolon. Hepatogastroenterology. 2012;59:2127–2131.PubMedCrossRef
22.
go back to reference Faussone-Pellegrini MS, Fociani P, Buffa R, Basilisco G. Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient. Gut. 1999;45:775–779.PubMedCrossRef Faussone-Pellegrini MS, Fociani P, Buffa R, Basilisco G. Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient. Gut. 1999;45:775–779.PubMedCrossRef
23.
go back to reference Meier-Ruge W. Desmosis of the colon: a working hypothesis of primary chronic constipation. Eur J Pediatr Surg. 1998;8:299–303.PubMedCrossRef Meier-Ruge W. Desmosis of the colon: a working hypothesis of primary chronic constipation. Eur J Pediatr Surg. 1998;8:299–303.PubMedCrossRef
24.
25.
go back to reference Meier-Ruge WA, Muller-Lobeck H, Stoss F, Bruder E. The pathogenesis of idiopathic megacolon. Eur J Gastroenterol Hepatol. 2006;18:1209–1215.PubMedCrossRef Meier-Ruge WA, Muller-Lobeck H, Stoss F, Bruder E. The pathogenesis of idiopathic megacolon. Eur J Gastroenterol Hepatol. 2006;18:1209–1215.PubMedCrossRef
26.
go back to reference Goerrtler K. Der konstruktive bau der menschlichen darmwand. Gegenbauers morphologisches Jahrbuch. 1932;69:329–379. Goerrtler K. Der konstruktive bau der menschlichen darmwand. Gegenbauers morphologisches Jahrbuch. 1932;69:329–379.
27.
go back to reference Goerrtler K. Der bau der “muscularis mucosae” des menschlichen darmes und ein befund über den bau seiner “muscularis propria”. Gegenbauers morphologisches Jarhbuch. 1949–1951;90:33–58. Goerrtler K. Der bau der “muscularis mucosae” des menschlichen darmes und ein befund über den bau seiner “muscularis propria”. Gegenbauers morphologisches Jarhbuch. 1949–1951;90:33–58.
29.
go back to reference Nardone DA, Reuler JB, Girard DE. Gastrointestinal complications of ehlers-danlos syndrome. N Engl J Med. 1979;300:863–864.PubMed Nardone DA, Reuler JB, Girard DE. Gastrointestinal complications of ehlers-danlos syndrome. N Engl J Med. 1979;300:863–864.PubMed
30.
go back to reference Fehlow P, Bernstein K, Tennstedt A, Walther F. Autismus infantum und exzessive aerophagie mit symptomatischem megakolon und ileus bei einem fall von ehlers-danlos syndrom. Pädiatrische Grenzgebiete. 1993;31:259–267. Fehlow P, Bernstein K, Tennstedt A, Walther F. Autismus infantum und exzessive aerophagie mit symptomatischem megakolon und ileus bei einem fall von ehlers-danlos syndrom. Pädiatrische Grenzgebiete. 1993;31:259–267.
31.
go back to reference Burcharth J, Rosenberg J. Gastrointestinal surgery and related complications in patients with ehlers-danlos syndrome: a systematic review. Dig Surg. 2012;29:349–357.PubMedCrossRef Burcharth J, Rosenberg J. Gastrointestinal surgery and related complications in patients with ehlers-danlos syndrome: a systematic review. Dig Surg. 2012;29:349–357.PubMedCrossRef
32.
go back to reference Kumar S, Appavu S, Abcavian H. Amyloidosis of the colon. Report of a case and review of the literature. Dis Colon Rectum. 1983;26:541–544.PubMedCrossRef Kumar S, Appavu S, Abcavian H. Amyloidosis of the colon. Report of a case and review of the literature. Dis Colon Rectum. 1983;26:541–544.PubMedCrossRef
33.
go back to reference Shamberger RC, Crawford JL, Kirkham SE. Progressive systemic sclerosis resulting in megacolon: a case report. JAMA. 1983;250:1063–1065.PubMedCrossRef Shamberger RC, Crawford JL, Kirkham SE. Progressive systemic sclerosis resulting in megacolon: a case report. JAMA. 1983;250:1063–1065.PubMedCrossRef
34.
go back to reference Brandwein M. Megacolon and volvulus complicating systemic sclerosis. Mt Sinai J Med. 1988;55:343–345.PubMed Brandwein M. Megacolon and volvulus complicating systemic sclerosis. Mt Sinai J Med. 1988;55:343–345.PubMed
35.
go back to reference Fikree A, Aziz Q, Grahame R. Joint hypermobility syndrome. Rheum Dis Clin North Am. 2013;39:419–430.PubMedCrossRef Fikree A, Aziz Q, Grahame R. Joint hypermobility syndrome. Rheum Dis Clin North Am. 2013;39:419–430.PubMedCrossRef
36.
go back to reference Fikree A, Grahame R, Aktar R, et al. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2014;12:1680.e2–1687.e2.CrossRef Fikree A, Grahame R, Aktar R, et al. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2014;12:1680.e2–1687.e2.CrossRef
37.
go back to reference Zarate N, Farmer AD, Grahame R, et al. Unexplained gastrointestinal symptoms and joint hypermobility: Is connective tissue the missing link? Neurogastroenterol Motil. 2010;22:e252–e278.CrossRef Zarate N, Farmer AD, Grahame R, et al. Unexplained gastrointestinal symptoms and joint hypermobility: Is connective tissue the missing link? Neurogastroenterol Motil. 2010;22:e252–e278.CrossRef
38.
go back to reference Law N, Bharucha A, Zinsmeister A. Rectal and colonic distention elicit viscerovisceral reflexes in humans. Am J Physiol Gastrointest Liver Physiol. 2002;283:384–389.CrossRef Law N, Bharucha A, Zinsmeister A. Rectal and colonic distention elicit viscerovisceral reflexes in humans. Am J Physiol Gastrointest Liver Physiol. 2002;283:384–389.CrossRef
39.
go back to reference Mollen RM, Salvioli B, Camilleri M, et al. The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol. 1999;94:751–756.PubMed Mollen RM, Salvioli B, Camilleri M, et al. The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol. 1999;94:751–756.PubMed
40.
go back to reference Sohn G, Yu CS, Kim CW, et al. Surgical outcomes after total colectomy with ileorectal anastomosis in patients with medically intractable slow transit constipation. J Korean Soc Coloproctol. 2011;27:180–187.PubMedCentralPubMedCrossRef Sohn G, Yu CS, Kim CW, et al. Surgical outcomes after total colectomy with ileorectal anastomosis in patients with medically intractable slow transit constipation. J Korean Soc Coloproctol. 2011;27:180–187.PubMedCentralPubMedCrossRef
41.
go back to reference Hassan I, Pemberton JH, Young-Fadok TM, et al. Ileorectal anastomosis for slow transit constipation: long-term functional and quality of life results. J Gastrointest Surg. 2006;10:1330–1336.; discussion 1336-1337.PubMedCrossRef Hassan I, Pemberton JH, Young-Fadok TM, et al. Ileorectal anastomosis for slow transit constipation: long-term functional and quality of life results. J Gastrointest Surg. 2006;10:1330–1336.; discussion 1336-1337.PubMedCrossRef
43.
go back to reference Shin A, Camilleri M, Kolar G, Erwin P, West CP, Murad MH. Systematic review with meta-analysis: highly selective 5-ht4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther. 2014;39:239–253.PubMedCrossRef Shin A, Camilleri M, Kolar G, Erwin P, West CP, Murad MH. Systematic review with meta-analysis: highly selective 5-ht4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther. 2014;39:239–253.PubMedCrossRef
44.
go back to reference O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12:540–548.PubMedCrossRef O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12:540–548.PubMedCrossRef
45.
go back to reference Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008;18:194–202.PubMedCentralPubMedCrossRef Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008;18:194–202.PubMedCentralPubMedCrossRef
46.
go back to reference Bharucha AE, Low P, Camilleri M, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013;62:708–715.PubMedCentralPubMedCrossRef Bharucha AE, Low P, Camilleri M, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013;62:708–715.PubMedCentralPubMedCrossRef
47.
go back to reference Tomita R, Sakurai K, Fujisaki S, Shibata M. Role of the enteric nervous system in the colon of patients with idiopathic megacolon. Hepatogastroenterology. 2012;59:2127–2131.PubMedCrossRef Tomita R, Sakurai K, Fujisaki S, Shibata M. Role of the enteric nervous system in the colon of patients with idiopathic megacolon. Hepatogastroenterology. 2012;59:2127–2131.PubMedCrossRef
48.
go back to reference Bouras E, Camilleri M, Burton D, Thomforde G, McKinzie S, Zinsmeister A. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001;120:354–360.PubMedCrossRef Bouras E, Camilleri M, Burton D, Thomforde G, McKinzie S, Zinsmeister A. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001;120:354–360.PubMedCrossRef
49.
go back to reference Shin A, Acosta A, Camilleri M, et al. The serotonin receptor 5-HT4 agonist YKP10811 accelerates intestinal transit and improves bowel functions in patients with functional constipation. Clin Gastroenterol Hepatol. 2014. doi:10.1016/j.cgh.2014.08.012. Shin A, Acosta A, Camilleri M, et al. The serotonin receptor 5-HT4 agonist YKP10811 accelerates intestinal transit and improves bowel functions in patients with functional constipation. Clin Gastroenterol Hepatol. 2014. doi:10.​1016/​j.​cgh.​2014.​08.​012.
50.
go back to reference Acosta A, Kolar G, Iturrino J, et al. A phase ii, single-center, randomized, double-blind, placebo-controlled, multiple-dose, 2-period, parallel-group study to evaluate the efficacy, safety, and pharmacodynamics of rm 131 administered to patients with chronic constipation. Gastroenterology. 2014;146:S364.CrossRef Acosta A, Kolar G, Iturrino J, et al. A phase ii, single-center, randomized, double-blind, placebo-controlled, multiple-dose, 2-period, parallel-group study to evaluate the efficacy, safety, and pharmacodynamics of rm 131 administered to patients with chronic constipation. Gastroenterology. 2014;146:S364.CrossRef
51.
go back to reference Washabau RJ, Holt D. Pathogenesis, diagnosis, and therapy of feline idiopathic megacolon. Vet Clin N Am Small Anim Pract. 1999;29:589–603.CrossRef Washabau RJ, Holt D. Pathogenesis, diagnosis, and therapy of feline idiopathic megacolon. Vet Clin N Am Small Anim Pract. 1999;29:589–603.CrossRef
Metadata
Title
Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults
Authors
Ralph Hurley O’Dwyer
Andrés Acosta
Michael Camilleri
Duane Burton
Irene Busciglio
Adil E. Bharucha
Publication date
01-08-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3645-5

Other articles of this Issue 8/2015

Digestive Diseases and Sciences 8/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine